NCT02144259

The Impact of Contraception on Postpartum Weight Loss

The Impact of Contraception on Postpartum Weight Loss: a Prospective Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: University of Pennsylvania · Academic / Other
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This is a prospective mixed methods study to assess weight changes in women randomized to receive Implanon ® or Depo Provera® (DMPA) immediately postpartum compared to women who choose non-hormonal contraception or no contraception immediately postpartum. After enrollment, subjects return for a visit at 3, 6 and 12 months postpartum to be asked a series of questions, take a pregnancy test, and be weighed. Total length of participation for each subject is 1 year or until pregnancy.

Conditions

• Weight

Interventions

Type	Name	Description
DRUG	DMPA immediately postpartum	DMPA is an intramuscular injection of 150mg of depot medroxyprogesterone acetate.
DRUG	Implanon immediately postpartum	Implanon ® is a subdermal implant that contains 68mg of etonogestrel.

Timeline

• Start date: 2011-04-01
• Primary completion: 2012-10-01
• Completion: 2012-10-01
• First posted: 2014-05-21
• Last updated: 2017-02-17
• Results posted: 2017-02-17

Locations

1 site across 1 country: United States